Drug
DCCR
DCCR is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
4
80%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Active, not recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 34 (80.0%)
Trials by Status
active_not_recruiting120%
withdrawn120%
completed360%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruitingphase_3
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
NCT05701774
completedphase_3
Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
NCT03714373
completedphase_3
A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
NCT03440814
withdrawnphase_3
An Open-Label Study of DCCR Tablet in Patients With PWS
NCT04086810
completedphase_1
Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
NCT02034071
Clinical Trials (5)
Showing 5 of 5 trials
NCT05701774Phase 3
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
NCT03714373Phase 3
Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
NCT03440814Phase 3
A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
NCT04086810Phase 3
An Open-Label Study of DCCR Tablet in Patients With PWS
NCT02034071Phase 1
Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5